Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:55 PM
Ignite Modification Date: 2025-12-25 @ 2:38 PM
NCT ID: NCT00528450
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00528450
Study Brief: Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
All Patients Tretinoin and Arsenic Trioxide With or Without Idarubicin None None 0 1 1 1 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
ALT, SGPT SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
AST, SGOT SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
Alkaline phosphatase SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTC-3.0 View
Bilirubin (hyperbilirubinemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTC-3.0 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders CTC-3.0 View
Glucose, high (hyperglycemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTC-3.0 View
Hemoglobin SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
Infection, other SYSTEMATIC_ASSESSMENT Infections and infestations CTC-3.0 View
Leukocytes (total WBC) SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
Lymphopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
Mood alteration - Anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders CTC-3.0 View
Neutrophils/granulocytes (ANC/AGC) SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
Pain - Head/headache SYSTEMATIC_ASSESSMENT General disorders CTC-3.0 View
Pain - Pain NOS SYSTEMATIC_ASSESSMENT General disorders CTC-3.0 View
Phosphate, low (hypophosphatemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTC-3.0 View
Platelets SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
Potassium, high (hyperkalemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTC-3.0 View
Pruritus/itching SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTC-3.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTC-3.0 View